Using PSMA-PET imaging and genomic testing to obtain better information earlier in the disease course changes what clinicians can do with diagnosis and treatment planning.
|Videos|July 27, 2022
Dr. Alexis Rompré-Brodeur on germline testing in renal cell carcinoma
Author(s)Urology Times staff
Advertisement
Alexis Rompré-Brodeur, MD, a urologic oncologist at McGill University discusses germline testing in patients with renal cell carcinoma. Rompré-Brodeur presented the study, “Germline testing in renal cell carcinoma: can enrichment features help predict germline alterations?” at the 2022 AUA Annual Meeting.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Urology Times
1
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
2
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
3
FDA updates in urology: September 2026
4
Enzalutamide plus salvage radiotherapy associated with improved PFS in high-risk BCR
5